172 related articles for article (PubMed ID: 33071173)
1. Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
Brandl A; Yonemura Y; Glehen O; Sugarbaker P; Rau B
Eur J Surg Oncol; 2021 Jan; 47(1):172-180. PubMed ID: 33071173
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
5. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis.
Hajjar R; Mercier F; Passot G; Pasquer A; Gelli M; Levine EA; Villeneuve L; Poncet G; Walter T; Glehen O
Eur J Surg Oncol; 2022 Jul; 48(7):1626-1630. PubMed ID: 35418324
[TBL] [Abstract][Full Text] [Related]
7. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
8. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study.
Yarema R; Mielko J; Fetsych T; Ohorchak M; Skorzewska M; Rawicz-Pruszyński K; Mashukov A; Maksimovsky V; Jastrzębski T; Polkowski W; Gyrya P; Kovalchuk Y; Safiyan V; Karelin I; Kopetskiy V; Kolesnik O; Kondratskiy Y; Paskonis M
Cancer Med; 2019 Jun; 8(6):2877-2885. PubMed ID: 31033239
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
11. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
Bonnot PE; Lintis A; Mercier F; Benzerdjeb N; Passot G; Pocard M; Meunier B; Bereder JM; Abboud K; Marchal F; Quenet F; Goere D; Msika S; Arvieux C; Pirro N; Wernert R; Rat P; Gagnière J; Lefevre JH; Courvoisier T; Kianmanesh R; Vaudoyer D; Rivoire M; Meeus P; Villeneuve L; Piessen G; Glehen O;
Br J Surg; 2021 Oct; 108(10):1225-1235. PubMed ID: 34498666
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
Rau B; Brandl A; Thuss-Patience P; Bergner F; Raue W; Arnold A; Horst D; Pratschke J; Biebl M
Gastric Cancer; 2019 Nov; 22(6):1226-1237. PubMed ID: 31065877
[TBL] [Abstract][Full Text] [Related]
14. Is there a role of repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with relapse from peritoneal metastatic disease? A survival analysis.
Spiliotis J; Prodromidou A; Ferfelis M; Iavazzo C; Tsiatas M; Vaxevanidou A; Metaxas T
J BUON; 2020; 25(5):2504-2509. PubMed ID: 33277875
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal metastasis in gastric cancer: results from the German database.
Rau B; Brandl A; Piso P; Pelz J; Busch P; Demtröder C; Schüle S; Schlitt HJ; Roitman M; Tepel J; Sulkowski U; Uzunoglu F; Hünerbein M; Hörbelt R; Ströhlein M; Beckert S; Königsrainer I; Königsrainer A;
Gastric Cancer; 2020 Jan; 23(1):11-22. PubMed ID: 31228044
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E
Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071
[TBL] [Abstract][Full Text] [Related]
17. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
van de Vlasakker VCJ; Lurvink RJ; Cashin PH; Ceelen W; Deraco M; Goéré D; González-Moreno S; Lehmann K; Li Y; Moran B; Morris DL; Piso P; Quadros CA; Rau B; Somashekhar SP; Sommariva A; van der Speeten K; Spiliotis J; Sugarbaker PH; Teo MCC; Verwaal VJ; Yonemura Y; Glehen O; de Hingh IHJT
Eur J Surg Oncol; 2021 Nov; 47(11):2888-2892. PubMed ID: 34020808
[TBL] [Abstract][Full Text] [Related]
18. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
19. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2015 May; 22(5):1673-9. PubMed ID: 25377640
[TBL] [Abstract][Full Text] [Related]
20. Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).
Goéré D; Passot G; Gelli M; Levine EA; Bartlett DL; Sugarbaker PH; Glehen O
Int J Hyperthermia; 2017 Aug; 33(5):520-527. PubMed ID: 28540827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
